HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mark Toshner Selected Research
Mark Toshner Research Topics
Disease
15
Pulmonary Hypertension
10/2021 - 11/2007
12
Pulmonary Arterial Hypertension
01/2022 - 11/2010
7
Familial Primary Pulmonary Hypertension
12/2021 - 02/2011
6
COVID-19
03/2022 - 01/2021
2
Hypoxia (Hypoxemia)
03/2022 - 01/2016
2
Thrombosis (Thrombus)
01/2022 - 01/2014
2
Cough
10/2021 - 01/2021
2
Ageusia (Hypogeusia)
10/2021 - 01/2021
2
Anosmia
10/2021 - 01/2021
2
Dyspnea (Shortness of Breath)
10/2021 - 01/2021
2
Fever (Fevers)
10/2021 - 01/2021
2
Heart Failure
11/2014 - 04/2011
1
Virus Diseases (Viral Diseases)
01/2022
1
Viral Pneumonia
01/2022
1
Pneumonia (Pneumonitis)
01/2022
1
Infections
10/2021
1
Heart Diseases (Heart Disease)
10/2020
1
Sarcoidosis (Schaumann Disease)
10/2020
1
Pulmonary Sarcoidosis
10/2020
1
Disease Susceptibility (Diathesis)
01/2020
1
Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2020
1
Starvation
04/2019
1
Gastroparesis
04/2019
1
Pulmonary Embolism
01/2019
1
Inflammation (Inflammations)
01/2019
1
Cardiac Arrhythmias (Arrythmia)
01/2019
1
Channelopathies
10/2018
1
Rheumatoid Arthritis
01/2018
1
Castleman Disease (Castleman's Disease)
01/2018
1
Mixed Connective Tissue Disease (MCTD)
01/2018
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2018
1
Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary)
11/2017
1
Rare Diseases (Rare Disease)
11/2017
1
Lymphadenopathy
11/2017
1
Vascular Remodeling
01/2016
1
Disease Progression
12/2014
1
Clinical Deterioration
04/2011
1
Congenital Heart Defects (Congenital Heart Defect)
10/2009
Drug/Important Bio-Agent (IBA)
4
Camphor
IBA
10/2021 - 01/2020
3
Interleukin-6 (Interleukin 6)
IBA
01/2022 - 01/2018
3
pro-brain natriuretic peptide (1-76)
IBA
01/2022 - 11/2007
3
Nucleic Acids
IBA
10/2021 - 01/2021
3
ChAdOx1 nCoV-19
IBA
10/2021 - 01/2021
3
Vaccines
IBA
10/2021 - 01/2021
2
Messenger RNA (mRNA)
IBA
03/2022 - 04/2019
2
RNA (Ribonucleic Acid)
IBA
03/2022 - 01/2020
2
Proteome
IBA
01/2022 - 01/2022
2
Biomarkers (Surrogate Marker)
IBA
01/2022 - 04/2011
2
Pharmaceutical Preparations
IBA
01/2022 - 10/2020
2
Imatinib Mesylate (Gleevec)
FDA Link
10/2021 - 11/2010
2
DNA (Deoxyribonucleic Acid)
IBA
11/2017 - 10/2016
1
Factor V (Coagulation Factor V)
IBA
03/2022
1
Brain Natriuretic Peptide (Natrecor)
FDA Link
01/2022
1
Biological Products
IBA
12/2021
1
MenACWY
IBA
10/2021
1
Proteins (Proteins, Gene)
FDA Link
01/2021
1
Blood Proteins (Serum Proteins)
IBA
10/2020
1
Sildenafil Citrate (Viagra)
FDA Link
10/2020
1
Bosentan (Tracleer)
FDA Link
10/2020
1
Gadolinium
IBA
10/2020
1
Epoprostenol (Prostacyclin)
FDA Link
Generic
10/2020
1
Iloprost (Ventavis)
FDA Link
10/2020
1
Natriuretic Peptides
IBA
01/2020
1
Anticoagulants
IBA
01/2020
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
04/2019
1
Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)
IBA
04/2019
1
Anti-Arrhythmia Agents
IBA
01/2019
1
Antigens
IBA
01/2019
1
N 30
IBA
01/2019
1
Potassium
IBA
10/2018
1
Interleukin-6 Receptors (Interleukin 6 Receptor)
IBA
01/2018
1
tocilizumab (atlizumab)
FDA Link
01/2018
1
Calcium Channels (Calcium Channel)
IBA
12/2017
1
Carbon Monoxide
IBA
11/2017
1
Prokaryotic Initiation Factor-2
IBA
11/2017
1
Bone Morphogenetic Proteins (Bone Morphogenetic Protein)
IBA
11/2017
1
Phosphotransferases (Kinase)
IBA
11/2017
1
Peroxidase (Myeloperoxidase)
IBA
10/2016
1
Leukocyte Elastase (Neutrophil Elastase)
IBA
10/2016
1
Arginase
IBA
01/2016
1
Transcription Factors (Transcription Factor)
IBA
01/2016
1
Lipopolysaccharides
IBA
10/2015
1
Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)
IBA
10/2015
1
Endothelin-1 (Endothelin 1)
IBA
11/2014
1
Endothelin Receptors (Endothelin Receptor)
IBA
11/2014
1
erucylphosphocholine
IBA
12/2012
1
Amiodarone (Amiodarona)
FDA Link
Generic
02/2011
1
Chemokine Receptors
IBA
10/2009
Therapy/Procedure
9
Endarterectomy (Thromboendarterectomy)
01/2021 - 11/2007
5
Therapeutics
04/2021 - 11/2010
1
Extracorporeal Membrane Oxygenation
01/2022
1
Catheters
04/2019
1
Central Venous Catheters
04/2019
1
Electric Countershock (Cardioversion)
01/2019
1
Immunomodulation
01/2018
1
Perioperative Period
05/2016
1
Transplantation
04/2011